EP3732294A4 - Compositions for the management of hyperglycemia and related conditions - Google Patents
Compositions for the management of hyperglycemia and related conditions Download PDFInfo
- Publication number
- EP3732294A4 EP3732294A4 EP18897769.8A EP18897769A EP3732294A4 EP 3732294 A4 EP3732294 A4 EP 3732294A4 EP 18897769 A EP18897769 A EP 18897769A EP 3732294 A4 EP3732294 A4 EP 3732294A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- hyperglycemia
- compositions
- management
- related conditions
- conditions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000001421 hyperglycemia Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/065—Diphenyl-substituted acyclic alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/02—Solvent extraction of solids
- B01D11/0203—Solvent extraction of solids with a supercritical fluid
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/02—Solvent extraction of solids
- B01D11/0288—Applications, solvents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/314—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/02—Solvent extraction of solids
- B01D11/0211—Solvent extraction of solids in combination with an electric or magnetic field
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/02—Solvent extraction of solids
- B01D11/0292—Treatment of the solvent
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/54—Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Botany (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Toxicology (AREA)
- Medical Informatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762610565P | 2017-12-27 | 2017-12-27 | |
PCT/US2018/067480 WO2019133588A1 (en) | 2017-12-27 | 2018-12-26 | Compositions for the management of hyperglycemia and related conditions |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3732294A1 EP3732294A1 (en) | 2020-11-04 |
EP3732294A4 true EP3732294A4 (en) | 2021-08-18 |
Family
ID=66949194
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP18897769.8A Pending EP3732294A4 (en) | 2017-12-27 | 2018-12-26 | Compositions for the management of hyperglycemia and related conditions |
EP18893434.3A Pending EP3731833A4 (en) | 2017-12-27 | 2018-12-26 | Compositions containing thymohydroquinone and their method of preparation |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP18893434.3A Pending EP3731833A4 (en) | 2017-12-27 | 2018-12-26 | Compositions containing thymohydroquinone and their method of preparation |
Country Status (11)
Country | Link |
---|---|
US (2) | US10881623B2 (en) |
EP (2) | EP3732294A4 (en) |
JP (2) | JP7012857B2 (en) |
KR (2) | KR102577863B1 (en) |
CN (2) | CN111542313B (en) |
AU (2) | AU2018397667B2 (en) |
BR (2) | BR112020012949A2 (en) |
CA (2) | CA3087050C (en) |
EA (2) | EA202091205A1 (en) |
WO (2) | WO2019133587A1 (en) |
ZA (2) | ZA202004532B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3965586A1 (en) * | 2019-05-07 | 2022-03-16 | Lynxit Sport Nutrition AS | Omega-3 beverage |
CN111214514B (en) * | 2020-03-10 | 2022-03-22 | 上海中医药大学 | Application of teasel roots and active components in teasel roots in blood sugar reduction |
WO2022132844A1 (en) * | 2020-12-15 | 2022-06-23 | Muhammed Majeed | Anti-viral compositions |
KR20230119160A (en) * | 2020-12-17 | 2023-08-16 | 새미-사빈사 그룹 리미티드 | Compositions targeting advanced glycation end product receptor (RAGE) in chronic inflammatory conditions |
CN114948915B (en) * | 2022-07-18 | 2023-10-24 | 广东省农业科学院动物卫生研究所 | Application of bailiquinone in preparation of anti-haemophilus parasuis drug |
WO2024073699A1 (en) * | 2022-09-29 | 2024-04-04 | Muhammed Majeed | Compositions for the management of hirsutism |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8535740B2 (en) * | 2002-11-22 | 2013-09-17 | Bionexus, Ltd. | Compositions from Nigella sativa |
US8029831B2 (en) * | 2008-07-29 | 2011-10-04 | Bionexus, Ltd. | Formulations containing thymoquinone for urinary health |
WO2005009332A2 (en) * | 2003-07-31 | 2005-02-03 | Palsamed (P.B.S.) Ltd. | Compositions-of-matter for lowering serum cholesterol and/or triglyceride level and methods of producing and using same |
GB0505909D0 (en) * | 2005-03-23 | 2005-04-27 | Univ Leeds | Formulations |
CN105106301A (en) * | 2006-08-09 | 2015-12-02 | 帝斯曼知识产权资产管理有限公司 | Novel agents for the treatment of disorders connected to impaired neurotransmission |
CN101781604A (en) * | 2010-03-11 | 2010-07-21 | 南京农业大学 | Method for extracting semen nigellae oil by using supercritical carbon dioxide |
US20160213727A1 (en) * | 2012-01-26 | 2016-07-28 | William G. Rohlfsen | Methods and Uses of High Thymoquinone and Thymohydroquinone Essential Oil of Monarda |
CN103948604A (en) * | 2014-05-20 | 2014-07-30 | 天津理工大学 | Application of hederagenin compound serving as medicament for treating liver cancer and preparation of hederagenin compound |
PL412214A1 (en) * | 2015-05-04 | 2016-11-07 | Biovico Spółka Z Ograniczoną Odpowiedzialnością | Composition of plants with anti-inflammatory, antiallergic and/or antiasthmatic properties and its applications |
-
2018
- 2018-12-26 AU AU2018397667A patent/AU2018397667B2/en active Active
- 2018-12-26 BR BR112020012949-6A patent/BR112020012949A2/en unknown
- 2018-12-26 CA CA3087050A patent/CA3087050C/en active Active
- 2018-12-26 KR KR1020207020094A patent/KR102577863B1/en active IP Right Grant
- 2018-12-26 CN CN201880083853.2A patent/CN111542313B/en active Active
- 2018-12-26 US US16/232,242 patent/US10881623B2/en active Active
- 2018-12-26 EA EA202091205A patent/EA202091205A1/en unknown
- 2018-12-26 AU AU2018397668A patent/AU2018397668B2/en active Active
- 2018-12-26 KR KR1020207020978A patent/KR102539298B1/en active IP Right Grant
- 2018-12-26 JP JP2020536249A patent/JP7012857B2/en active Active
- 2018-12-26 JP JP2020536250A patent/JP7089033B2/en active Active
- 2018-12-26 CN CN201880083854.7A patent/CN111566218B/en active Active
- 2018-12-26 WO PCT/US2018/067478 patent/WO2019133587A1/en unknown
- 2018-12-26 EP EP18897769.8A patent/EP3732294A4/en active Pending
- 2018-12-26 CA CA3087042A patent/CA3087042C/en active Active
- 2018-12-26 US US16/232,197 patent/US10945969B2/en active Active
- 2018-12-26 EP EP18893434.3A patent/EP3731833A4/en active Pending
- 2018-12-26 WO PCT/US2018/067480 patent/WO2019133588A1/en unknown
- 2018-12-26 EA EA202091184A patent/EA202091184A1/en unknown
- 2018-12-26 BR BR112020012333-1A patent/BR112020012333A2/en active Search and Examination
-
2020
- 2020-07-22 ZA ZA2020/04532A patent/ZA202004532B/en unknown
- 2020-07-22 ZA ZA2020/04531A patent/ZA202004531B/en unknown
Non-Patent Citations (4)
Title |
---|
AFTAB AHMAD ET AL: "A review on therapeutic potential of Nigella sativa: A miracle herb", ASIAN PACIFIC JOURNAL OF TROPICAL BIOMEDICINE, vol. 3, no. 5, 1 May 2013 (2013-05-01), China, pages 337 - 352, XP055559274, ISSN: 2221-1691, DOI: 10.1016/S2221-1691(13)60075-1 * |
HAWSAWI ZUBAIDA A ET AL: "EFFECT OF NIGELLA SATIVA (BLACK SEED) AND THYMOQUINONE ON BLOOD GLUCOSE IN ALBINO RATS", 1 July 2001 (2001-07-01), pages 242 - 244, XP055818581, Retrieved from the Internet <URL:https://www.annsaudimed.net/doi/pdf/10.5144/0256-4947.2001.242> [retrieved on 20210628] * |
MEDDAH B ET AL: "Nigella sativa inhibits intestinal glucose absorption and improves glucose tolerance in rats", JOURNAL OF ETHNOPHARMACOLOGY, ELSEVIER IRELAND LTD, IE, vol. 121, no. 3, 30 January 2009 (2009-01-30), pages 419 - 424, XP025768162, ISSN: 0378-8741, [retrieved on 20081117], DOI: 10.1016/J.JEP.2008.10.040 * |
RAZAVI B. M. ET AL: "A review of the effects of Nigella sativa L. and its constituent, thymoquinone, in metabolic syndrome", JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, vol. 37, no. 11, 15 August 2014 (2014-08-15), pages 1031 - 1040, XP055818575, Retrieved from the Internet <URL:http://link.springer.com/article/10.1007/s40618-014-0150-1/fulltext.html> DOI: 10.1007/s40618-014-0150-1 * |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3704239A4 (en) | Casz compositions and methods of use | |
EP3823673A4 (en) | Anti-cd112r compositions and methods | |
EP3595653A4 (en) | Compositions of plinabulin and use thereof | |
EP3704254A4 (en) | Cas12c compositions and methods of use | |
EP3600325A4 (en) | Novel compositions and methods | |
EP3576782A4 (en) | Construct-peptide compositions and methods of use thereof | |
EP3337823A4 (en) | Carrier-binding agent compositions and methods of making and using the same | |
EP3732294A4 (en) | Compositions for the management of hyperglycemia and related conditions | |
EP3600372A4 (en) | Synthekine compositions and methods of use | |
EP3166892A4 (en) | Scale-inhibition compositions and methods of making and using the same | |
EP3720421A4 (en) | Compositions and methods for the treatment of metabolic conditions | |
EP3676247B8 (en) | Aztreonam derivatives and uses thereof | |
EP3790861A4 (en) | Senolytic compositions and uses thereof | |
EP3423404A4 (en) | New germanosilicate compositions and methods of preparing the same | |
EP3706558A4 (en) | Compositions and methods for aquaculturing | |
EP3250618A4 (en) | Silicone acrylate compositions and methods of preparing the same | |
TWI799417B (en) | Biopharmaceutical compositions and related methods | |
EP3844500A4 (en) | Rp182 compositions and methods | |
EP3724293A4 (en) | Asphalt compositions and methods of using the same | |
EP3773654A4 (en) | Polypharmaceutical drug compositions and related methods | |
EP3687475A4 (en) | Stabilization of epinephrine formulations | |
EP3716766A4 (en) | Benzoxaborole compounds and formulations thereof | |
EP3661505A4 (en) | Benzothiazole and related compounds | |
EP3113774A4 (en) | Compositions of grapiprant and methods for using the same | |
EP3612230A4 (en) | Palbociclib compositions and methods thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20200619 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Free format text: PREVIOUS MAIN CLASS: C12N0015810000 Ipc: A61K0031050000 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20210715 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 31/05 20060101AFI20210709BHEP Ipc: A61K 31/065 20060101ALI20210709BHEP Ipc: A61K 31/122 20060101ALI20210709BHEP Ipc: A61K 31/19 20060101ALI20210709BHEP Ipc: A61K 31/191 20060101ALI20210709BHEP Ipc: A61P 29/00 20060101ALI20210709BHEP Ipc: A61P 3/10 20060101ALI20210709BHEP Ipc: A61P 39/06 20060101ALI20210709BHEP Ipc: A61K 36/71 20060101ALI20210709BHEP Ipc: A61K 47/12 20060101ALI20210709BHEP Ipc: A61K 47/22 20060101ALI20210709BHEP Ipc: C12N 15/81 20060101ALI20210709BHEP Ipc: C12N 9/42 20060101ALI20210709BHEP Ipc: C12P 19/02 20060101ALI20210709BHEP Ipc: B01D 11/02 20060101ALI20210709BHEP |
|
RAP3 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: SAMI-SABINSA GROUP LIMITED |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20230524 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Free format text: PREVIOUS MAIN CLASS: A61K0031050000 Ipc: A61K0031122000 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: B01D 11/02 20060101ALI20240814BHEP Ipc: C12P 19/02 20060101ALI20240814BHEP Ipc: C12N 9/42 20060101ALI20240814BHEP Ipc: C12N 15/81 20060101ALI20240814BHEP Ipc: A61K 47/22 20060101ALI20240814BHEP Ipc: A61K 47/12 20060101ALI20240814BHEP Ipc: A61K 36/71 20060101ALI20240814BHEP Ipc: A61P 3/10 20060101ALI20240814BHEP Ipc: A61K 31/122 20060101AFI20240814BHEP |